Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial

Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record is no longer displayed; the page now shows a 403 Forbidden error instead of the study details and results.
    Difference
    21%
    Check dated 2026-10-07T00:38:23.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, so the study details are not displayed. The page shows the error screen instead of the expected content.
    Difference
    21%
    Check dated 2026-09-23T00:43:46.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a new release of the site's software. This change does not modify the study content displayed on the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:01:52.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.6 updated from v3.6.5 on the page, indicating a small maintenance update to the study details page.
    Difference
    0.0%
    Check dated 2026-09-01T20:43:39.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A funding identifier '2015 ( U.S. NIH Grant/Contract )' was added to the Study ID Numbers. This adds NIH funding attribution to the study record but does not change the study design or participant criteria.
    Difference
    0.0%
    Check dated 2026-08-25T19:39:03.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a minor metadata/template update to the page without altering study content or results.
    Difference
    0.0%
    Check dated 2026-08-11T13:47:37.000Z thumbnail image

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.